Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Obici

Showing results (31-40 of 204) with videos related to

Pageof 21
Sort By:
Journal of the Neurological Sciences|September 1, 2024
AA amyloidosis: An uncommon case presenting with a polyneuropathyMaria Ausilia Sciarrone, Francesca Vitali, Angela Romano, et al.
Current Opinion in Neurology|January 7, 2016
Sixty years of transthyretin familial amyloid polyneuropathy (TTR-FAP) in Europe: where are we now? A European network approach to defining the epidemiology and management patterns for TTR-FAPYesim Parman, David Adams, Laura Obici, et al.
Neurology and Therapy|October 1, 2020
A Narrative Review of the Role of Transthyretin in Health and DiseaseMarcia Almeida Liz, Teresa Coelho, Vittorio Bellotti, et al.
Annals of the Rheumatic Diseases|December 22, 2010
Favourable and sustained response to anakinra in tumour necrosis factor receptor-associated periodic syndrome (TRAPS) with or without AA amyloidosisLaura Obici, Antonella Meini, Marco Cattalini, et al.
Current Opinion in Neurology|January 7, 2016
Recommendations for presymptomatic genetic testing and management of individuals at risk for hereditary transthyretin amyloidosisLaura Obici, Jan B Kuks, Juan Buades, et al.
Advances in Therapy|September 1, 2023
Peripheral Nervous, Hepatic, and Gastrointestinal Endpoints for AL Amyloidosis Clinical Trials: Report from the Amyloidosis Forum Multi-organ System Working GroupMichelle L Mauermann, John O Clarke, William J Litchy, et al.
Clinical Chemistry and Laboratory Medicine|June 17, 2009
Proteomics in protein misfolding diseasesMonica Stoppini, Laura Obici, Francesca Lavatelli, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 12, 2017
Diagnostic challenges in hereditary transthyretin amyloidosis with polyneuropathy: avoiding misdiagnosis of a treatable hereditary neuropathyAndrea Cortese, Elisa Vegezzi, Alessandro Lozza, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|September 19, 2022
Impact of baseline polyneuropathy severity on patisiran treatment outcomes in the APOLLO trialDianna Quan, Laura Obici, John L Berk, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 5, 2011
Effect of the amyloidogenic L75P apolipoprotein A-I variant on HDL subpopulationsMonica Gomaraschi, Laura Obici, Sara Simonelli, et al.
Pageof 21

Showing results (31-40 of 204) with videos related to

Sort By:
Pageof 21
Journal of the Neurological Sciences|September 1, 2024
AA amyloidosis: An uncommon case presenting with a polyneuropathyMaria Ausilia Sciarrone, Francesca Vitali, Angela Romano, et al.
Current Opinion in Neurology|January 7, 2016
Sixty years of transthyretin familial amyloid polyneuropathy (TTR-FAP) in Europe: where are we now? A European network approach to defining the epidemiology and management patterns for TTR-FAPYesim Parman, David Adams, Laura Obici, et al.
Neurology and Therapy|October 1, 2020
A Narrative Review of the Role of Transthyretin in Health and DiseaseMarcia Almeida Liz, Teresa Coelho, Vittorio Bellotti, et al.
Annals of the Rheumatic Diseases|December 22, 2010
Favourable and sustained response to anakinra in tumour necrosis factor receptor-associated periodic syndrome (TRAPS) with or without AA amyloidosisLaura Obici, Antonella Meini, Marco Cattalini, et al.
Current Opinion in Neurology|January 7, 2016
Recommendations for presymptomatic genetic testing and management of individuals at risk for hereditary transthyretin amyloidosisLaura Obici, Jan B Kuks, Juan Buades, et al.
Advances in Therapy|September 1, 2023
Peripheral Nervous, Hepatic, and Gastrointestinal Endpoints for AL Amyloidosis Clinical Trials: Report from the Amyloidosis Forum Multi-organ System Working GroupMichelle L Mauermann, John O Clarke, William J Litchy, et al.
Clinical Chemistry and Laboratory Medicine|June 17, 2009
Proteomics in protein misfolding diseasesMonica Stoppini, Laura Obici, Francesca Lavatelli, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 12, 2017
Diagnostic challenges in hereditary transthyretin amyloidosis with polyneuropathy: avoiding misdiagnosis of a treatable hereditary neuropathyAndrea Cortese, Elisa Vegezzi, Alessandro Lozza, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|September 19, 2022
Impact of baseline polyneuropathy severity on patisiran treatment outcomes in the APOLLO trialDianna Quan, Laura Obici, John L Berk, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 5, 2011
Effect of the amyloidogenic L75P apolipoprotein A-I variant on HDL subpopulationsMonica Gomaraschi, Laura Obici, Sara Simonelli, et al.
Pageof 21